Xylem Inc (NYSE:XYL) insider Kenneth Napolitano sold 5,000 shares of the business’s stock in a transaction that occurred on Monday, July 8th. The stock was sold at an average price of $81.96, for a total transaction of $409,800.00. Following the completion of the transaction, the insider now owns 46,228 shares in the company, valued at approximately $3,788,846.88. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
Kenneth Napolitano also recently made the following trade(s):
- On Monday, June 3rd, Kenneth Napolitano sold 5,000 shares of Xylem stock. The stock was sold at an average price of $75.13, for a total transaction of $375,650.00.
- On Monday, May 6th, Kenneth Napolitano sold 5,000 shares of Xylem stock. The stock was sold at an average price of $80.45, for a total transaction of $402,250.00.
NYSE:XYL opened at $81.15 on Friday. The company has a fifty day moving average of $79.70. The company has a market cap of $14.59 billion, a price-to-earnings ratio of 28.18, a P/E/G ratio of 1.55 and a beta of 1.23. The company has a quick ratio of 1.02, a current ratio of 1.44 and a debt-to-equity ratio of 0.73. Xylem Inc has a twelve month low of $60.65 and a twelve month high of $85.39.
The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 27th. Stockholders of record on Thursday, May 30th were paid a $0.24 dividend. The ex-dividend date of this dividend was Wednesday, May 29th. This represents a $0.96 annualized dividend and a dividend yield of 1.18%. Xylem’s dividend payout ratio is currently 33.33%.
XYL has been the topic of a number of recent analyst reports. Janney Montgomery Scott upgraded shares of Xylem from a “neutral” rating to a “buy” rating and set a $86.00 price target on the stock in a research report on Friday, May 3rd. Stifel Nicolaus set a $95.00 price target on shares of C.H. Robinson Worldwide and gave the stock a “buy” rating in a research report on Friday, May 3rd. Zacks Investment Research upgraded shares of Zymeworks from a “hold” rating to a “buy” rating and set a $18.00 price target on the stock in a research report on Saturday, April 13th. Cowen boosted their price target on shares of WestJet Airlines from C$22.00 to C$31.00 in a research report on Tuesday, May 14th. Finally, ValuEngine upgraded shares of Xylem from a “hold” rating to a “buy” rating in a research report on Friday, June 21st. One analyst has rated the stock with a sell rating, five have given a hold rating and ten have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $79.60.
Large investors have recently added to or reduced their stakes in the company. Sandy Spring Bank increased its stake in Xylem by 101.2% during the 1st quarter. Sandy Spring Bank now owns 338 shares of the industrial products company’s stock valued at $27,000 after purchasing an additional 170 shares in the last quarter. Cullen Frost Bankers Inc. bought a new stake in Xylem during the 1st quarter valued at $28,000. Meridian Wealth Management LLC bought a new stake in Xylem during the 1st quarter valued at $30,000. Liberty Wealth Management LLC bought a new stake in Xylem during the 4th quarter valued at $35,000. Finally, BSW Wealth Partners bought a new stake in Xylem during the 1st quarter valued at $45,000. Institutional investors own 85.30% of the company’s stock.
Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.